companies that have pushed these drugs like pharma johnson and johnson in attack wait i think that last one is from the movie office space. and their brand of pain relief relies a lot more on relieving stress through physical activity. but one former company you may not have heard of is insists manufacturer of subsists and under the tongue spray containing the powerful opioid. and only meant for breakthrough pain in cancer patients but while substance is only f.d.a. approved for cancer patients insists thought why should cancer patients be the only people to experience pain relief from subsystem. and it's that not so legal shift which led several former incessant lawyers the file whistleblower lawsuits alleging that the addictive drug was marketed to patients who suffered from all kinds of pain not just cancer patients with breakthrough pain and detailing dubious sales tactics like taking doctors to strip clubs paying kickbacks for more prescriptions and posing as doctors representatives and where to get insurance to cover the drug according to two different complaints sales reps were t

and the pharma names are coming in and the tobacco are seeing erosion within the usage.d, just trends dropping off we're seeing it obviously in big pharma with certain franchisees that need full-time growth this is the opportunity and it's the long-term opportunity play for both alcohol, beverage and for big-cap pharma i think. >> macy's getting crushed on earnings and they're betting on a different retail stock and we'll tell you what that is and plus bitcoin staging an epic comeback and is the worst really over, or is the big move a head fake more fast money in two customizae options chains? ones that make it fast and easy to analyze and take action? how about some of the lowest options fees? are you raising your hand? good then it's time for power e*trade the platform, price and service that gives you the edge you need. alright one quick game of rock, paper, scissors. 1, 2, 3, go. e*trade. the original place to invest online. you mighyour joints...ng for your heart... or your digestion... so why wouldn't you take something for the most important part of you... your br

this pharma is being advised to spray fungicide to protect his crops. —— farmer.es can bea —— farmer. although these measures can be a big help, poor communities are can be a big help, poor communities a re often can be a big help, poor communities are often unaware of how vulnerable they actually are the extreme weather, or what they can do to lower the risks. another platform being used by the charity is setting out to assess just this, measuring the strengths and weaknesses of communities like those in this district. using the flood resilience management toolkit, representatives from the charity visit different communities to look at factors such as what crops are being grown, weather patterns, what large buildings exist, and the flood prevention measures that are already in place. in all, the technology looks at 88 different indicators to come up with a very realistic picture of how an area can cope with bad weather. it is quite a departure from traditional outlooks, which mostly considered factors such as dams and reservoirs. the thinking behind this technolo

joined by the founder of this pharma company.based on the applied market value of this company just listed. thank you so much for joining me. it is an exciting day for the and the stock exchange, as it is the first company to list under the new rules. excited, to be the first company ever listed on this new stock exchange. we are so excited. sophie: prior to this, you were considering china, united states as potential venues. why did you choose hong kong? jinzi: ipo's one of the most important events for a biotech company. we want to evaluate the capital markets and decided to go with an ipo in hong kong. hong kong has international access to the capital market. we were thinking about our strategy as a biotech company, focusing on china and going global. you are building a product pipeline. what are you hoping to do from here on out? jinzi: the are an innovative rmb company -- we are an innovative rnd company. we focus on eliminating cancer and liver diseases. we serve 25% of the japanese population and their families. we address

if you're aware of this country's opioid up at him and then you're probably familiar with the huge pharma companies that have pushed these drugs like pharma johnson and johnson in attack wait i think that last one is from the movie office space. and their brand of pain relief relies a lot more on relieving stress through physical activity. but one former company you may not have heard of is insists manufacturer of subsists and under the tongue spray containing the powerful baton and only meant for breakthrough pain in cancer patients but while substance is only f.d.a. approved for cancer patients insist on why should cancer patients be the only people to experience pain relief from subsystem. and that not so legal shift which led several former incessant lawyers the file whistleblower lawsuits alleging that the addictive drug was marketed to patients who suffered from all kinds of pain not just cancer patients with breakthrough pain and detailing dubious sales tactics like taking doctors to strip clubs paying kickbacks for more prescriptions and posing as doctors representatives and where

>> by the way, i don't make such a big dis iksz between biotech and pharma they're both producing drugs a chemistry-based. the other is a protein and dna based method of generating the drugs. all of them got cheap. there's names like allergan, and it's clearly bottom. when tipper got in, when icahn got in, that set the bottom. it's going higher. i'm sure you set the trend for those guys also look at celegene, and bertha mentioned regeneron it's over a longer time period, but over the last six months or so, it's really rallied quite nicely the whole selktor is taking off here >> there are clear stakes between the two. the one is being biotech could be a one product company, and that makes it look easy. in fact, some of them can really blow up and i bought china biologics today. it's been a great stock off and on one at 1 10 per share. straightened below that, and one 18 per share >> china biologics >> they make blood operate in china >> gillead gild, stock is in the 70s. they're big big upside calls for the last several weeks watch that one, brian. >> upside calls, gillead, china logics

thishas been the place to be. >> well, i'm long in pharma big-time because it has all the things i love. tremendous cash flow, fantastic balance sheets, big, succulent dividends, but i would also add to that that there's some really good opportunity in the european pharma, because they're getting bashed every time trump takes a shot at the eu some of them are swiss companies like roche and glaxo and all the rest of these trade at a discount because of the trump bashing so i loaded up on those too. biotech is a different gig i've learned the hard way through all the trials and errors, every time a drug fails if you own that heavy, you get slaughtered. so i use the ibb now i started buying ibb in the hillary bashing days every time she'd take a shot at it, it would trade down, it was a good thing to buy. same thing used to happen with trump but now it's ignoring him on drug pricing. it's been a great performer. >> four months in a row of gains for the ibb. kevin will answer your questions along with the other traders we'll do that in two minutes keep them coming, it's not too late cnbc.co

if you're aware of this country's opioid epidemic then you're probably familiar with the huge pharma companies that have pushed these drugs like thirty pharma johnson and johnson in attack wait i think that last one is from the movie office space and their brand of pain relief relies a lot more on relieving stress through physical activity. but one former company you may not have heard of is insists manufacturer of subsists and under the tongue spray containing the powerful opioid by.

opioids have been highly regulated since the '20's, but in 1996 perdue pharma released oxycodone., perdue saw an opportunity to market the new drug beyond the end of life treatment. objecti o oxycontin was marketed with a low risk of addiction. when the fda approved it, it attached a warning to limit competitive promotion. a warning perdue seemed to effectively ignore. sales reps pushed gifts, pre lunches and branded swag in doctor's offices across the country, even sending free 30-day supplies of the pills. and opioids are very big business. there are more than a dozen manufacturers of brand name opioids. many of them make several different opioid products. and those companies spent more than $46 million to doctors to market the drugs. it's paying off. industry made $14.7 billion in 2015. revenue is expected to jump in 2020. joining me now a long time reporter for the roanoke times. now she's author the "dope sick." an in-depth look of addiction and the quick send that traps millions. where much of the information we just reported came from. so beth, walk me through it. how does

it means the trump administration is able to undermine access, it means the private industry and pharma is able to make money off of denying people care, and the only alternative is real medicare for all. many of our members are in the democratic party. many of our members want to push the democratic party to the and many do not trust the party at all. we have one foot in and one foot out. we do not trust the institution. host: who are some of the specific members of the democratic party that you do not trust and that you think are introducing half measures and claiming victory? guest: i think there are multiple bills floating around now. i just heard the representative from new mexico talking about is medicare buy-in plan and he called it medicare for all. that is in a deliberate attempt to muddy the waters. we saw paul krugman wrote times"for the "new york writing this idea that the medicare for all means expanded care and that is not true. universal program that everybody is in, we need a program weather is not an insurance executive between you and your doctor, and we need a program

year of his baking in so tropical heat crops across the continent withering german pharma heiko turn as harvest is history. we've had to rate the feet would been storing for winter with nothing in the fields we can't put the young animals out to graze they get winter feed in the sheds because the fields are totally scorched. michael turner expects his losses to top two hundred thousand euros and he's only one of the many farmers who face ruin the family. facing the worst harvest of the century many farms face the prospect of going under crop losses are in the range of fifty to seventy percent we're calling on the government for a crisis aid program and prison is. germany's farmers association would like a billion euros from berlin and says that would go some way at least to ease the effects of harvest which are projected to be well down on last year as things stand right now though farmers aren't likely to see any fast cash agriculture minister yulia clarke no wants to see what happens before deciding at the end of august climatologist say the parched fields droughts and rising tempe

are after companies like canopy are also developing alternative medical products potentially giving pharma companies a run for their money. that's all for this edition of the business thank you very much for watching we'll see you next time or whenever we want on the w. dot com stay with us. by his parents. by wolves this isn't the story. it's the story. and it's. the for the seventy two year old spaniard lives with fellowship. now he's passing on his. nature on. next on the d.w.i. . entered the conflict zone confronting the powerful. as f.b.i. director james comey was always pretty well known but when donald trump five him last year his forefoot a measure of me this week he's my guest here in by the way he's promoting a book even as he faces new challenges of insubordination so what's the truth conflicts of. in sixty minutes g.w. . they make a commitment. they find solutions. they inspire. africa on the move. stories from both people who make no difference shaping their nation. and their continent of africa on the move stories about motivational change makers taking their destinies into t

hit german pharma has when government date it's nowhere near enough although they really need is bright. and game on we look at what's pushing people's buttons at the world's biggest computer games event. i've been fizzling let's do business europe is baking in its hottest summer since nineteen seventy six and there's hardly any rain that's threatening the livelihoods of thousands of follows. drought is causing havoc around the world no clouds in sight in europe as you can see from the international space station that means water shortages crop losses and wildfires wide areas of australia are also stricken by drought the worst in decades farmers are finding it hard to keep their animals alive state aid has been allocated to landholders the u.s. state of california is also facing severe drought water supplies have been declining for decades but this year is especially grim more wheat and corn will be consumed in twenty eighteen they can be produced reserves the dwindling. germany has the amounts three hundred forty million euros to help farmers if by drought as the result of a cabinet me

german company it's likely that the american position will prevail and comment briefly in a few cases pharma companies did manage to get more control over whether their products were used in executions or not what's the difference here. well in those cases the medications were very specific the companies involved in those cases found it much easier to control that distribution in the case of those medications of cuisine use of muscle relax and and a chemical that can stop the heart function. they are widely used in the u.s. and many clinics and the state of nebraska can get them quite easily contribution in frankfurt thank you. now a twelve year wait is over earlier today ikea the world's largest furniture retailer opened its doors in india in the southern city of heider about now it's an outsized project the thirty seven thousand square meter showroom is expected to draw in seven million shoppers a year in store employees almost one thousand people more stuff than any other ikea branch in the world the swedish furniture maker says it will invest one and a half billion dollars in india a bet

. >> if you look not only big cap pharma but bio tech has been on fire ever since.d i still think their names will work. i really think this comes down to people finally see the pull size off the back. >> bottom line here is the sector you continue to see beat and raise in the second quarterquarter, they got possibly five new pipeline drugs come through in 2020 but i think the valuations are very interesting here. great balance sheet management, great dividends, buy backs >> mike, what about the big cap pharma versus these bio tech names? >> i think big cap has a lot of room again, valuations still make sense. i do think what hurt these stocks for a long time, they were under sort of the myriad of bad news from the administration in terms of big cap pharma i think that bulls eye is off, and i think people are coming to that realization now >> all i would say in big cap pharma versus bio tech, look at the chart going back two years this is fantastic chart. it's been slow and steady. the top four or five names in that etf i'd stay with bio tech >> if you and mike agre

a want to pull up a purdue pharma quote.ard to present a are substantial defenses to these claims." they are saying blame the fda, the eda. why is it their fault and not the drug regulators? guest: for new is talking mighty big because they are already trying to set up for bankruptcy. that is the next thing we will allpurdue do, having killed these people and created this catastrophic economic disaster all over the country. the next thing they would do is try to get court protection and bankruptcy. so why are they responsible? purdue are the people who created the lie. story,nt out with this telling everybody, telling doctors that we have a new product that is not addictive. don't worry about it, dr.. you can prescribe as many as you want. the doctors believed them because they had by austin toots -- they had people getting paid to say, doc, would you write a piece of literature to say this is not addictive? you had it happening all over the country. this was driven by the industry. the fda has been totally dysfunctional whe

pharma. customers will only from the work work for jobs it's also straight rated it makes makes it a much more. we haven't. got any idea what it what do you make. and the season of that was. due canada [inaudible] you should. i'll be. holding the prime minister or as soon as we'll we'll we'll do know that. many men and women within this enough as a as a possible. she had had a force. for term terms maximize current organisers responding days a new address makes her feel deal will. even even in atlanta. now but the country's futur. this is morning. incoming administration a hundred on as. one first says as he he should you necessary any any version of nafta. in the coming days we will continue trial version she was kind of out of the which is always available. trade track tacked. on it. but it's not about that. you are you as markets are certainly on them that afternoon the dow jones and some one hundred six point point after. going in and out here there than a benefit triggers resolution inte

devices to services, to insurance names to so many names that are working it's not just bio-tech and pharma although it's proportionately represented there. there are a lot of great fundamental stories that are playing out and that's why the sector is doing well >> let's get into some of our specific picks a turn from what we're talking about but i want to make sure we get these. talk to me about acuvision blaze ar blazeard an interesting dynamic again, long-term vision of this stock. there's a division that says 60% of americans play some kind of a game on a daily basis. more than 39% are older than 36. so, we can't blame our kids for this anymore, okay again, i'm taking perspective saying long-term trend, where are we going the digital platform of gaming is just starting e-sports is just starting. there's a huge championship going on in columbus, ohio, where people are paying 50 bucks a ticket to watch others play games. >> they put 11,000 people in barkley center recently. >> so acuvision blabou activisie believe -- >> is it just one party over some other names >> it's the game, right? >

conservatives also have davis for him now julie bishop she seems on the surface to be a strong candidate as pharma looks to she's all well. but she has not so good credentials with more domestic medals in the past only briefly she didn't perform rightly then so she would place in third place to the battle between the other two what sort of shape is the opposition in australia you know a i sort of think about if you compare it to some of the some of the political dramas they see in the u.k. where people think oh it's a great chance for the labor party because there's all this infighting on the other side in the u.k. the labor party doesn't have strength what's it like in australia. strong and united bill shorten is not that much but is popular leader in the country but the labor party you seen as having a good alternative to the government they're not fighting among themselves but got a series of strong policy positions advanced by bill shorten at times as well but all the time and so they're seen as having credibility when i know you'll remember three years ago four years ago when they were doing

there are a lot more seniors getting overcharged for their prescriptions than there are pharma ceos getting rich gouging people on drug prices. [applause] yeah.arren: lot more families that would benefit from a childcare tax credit than there are families that pay the estate tax. there are a lot more working moms and dads who go to bed worried about making the mortgage payments than there are ceos who the to bed thinking about buying one more vacation home. in a democracy, all of these moms and dads and seniors and students ought to add up to four thano more than -- to more a handful of ceos and billionaires. but somehow, working people these days have to fight uphill to get heard, let alone to get their way in washington. in fact, the hill is steeper than ever before. here is my question, what is it about our politics that prevents our government from working for working people? how come the majority never gets to rule in washington anymore? i can think of three things. one, because of citizens united and the revolving door between industry and government. [applause] sen. warren: because o

i like merck, merck and pfizer and the big pharma names and the street expectations for one of the keyct is incredibly low. so the earnings power behind that will keep the story intact. i think it's a name that's underownid and think people will continue to gravitate toward it. pfizer is another one in the sector that i love, too. >> talk about a space that's come to life 30, 40 days or so it's healthcare. >> absolutely. these were underowned. these two names in particular were under owned and pfizer, i would say there's a bigger short component there and that may settle a little bit, but ultimately >> i just think and this is big-cap pharma is what this is and ultimately, these companies have done nothing for a long time and not that they're not great companies, they have pristine balance sheets and pay great dividends and they're great value traps and they're not executing every single day and some of the same issues including the pipeline including the regulatory pressure does not change and i don't think it will change tomorrow. >> embedded is not coincidence in my opinion. pfizer

plus, this mom says big pharma is holding her daughter's life hostage. soledad: why does it make you cry? doreen: you watch your child struggle. you watch them try to get better. announcer: they can get better -- if the price is right. and lessons learned. one year after a white supremacist rally rock charlottesville, can the first black woman mayor help the city keel old and new wounds? soledad: i am soledad o'brien. "matter of fact with soledad o'brien." the russians are coming again. the intelligence community says no mistake about it, our electoral system is still a hot target for hackers -- especially agents of the russian government. we're less than 100 days until the midterms. and despite warnings from intelligence officials that foreign governments will try to interfere, the senate shot down a proposal that would have given states an extra $250 million to beef up security. 46 democrats and only one republican, senator bob corker, supported the measure. earlier this year, congress gave states $380 million to safeguard the midterm elections. and re

let's check the dow 30, big pharma pfizer and merck holding gains along with travelers and the down day on wall street there is some green up there, walgreens, boots, verizon and 3 m, in the green the dow up 182 a lot better than it was this morning when it was down more than 300 points and a comeback, kind of. up next trade wars blamed for the days sell-off but could a trade war turn it all around? the mexican trade minister is in the nations capitol. edward lawrence will have the latest on finding a deal for a new nafta, that's next on countdown. >> on the next kennedy the president's war of words with former white house aid omarosa continues, how much nasty will it get? join me right here. .s. it's america's most popular street name. but allstate agents know that's where the similarity stops. if you're on park street in reno, nevada, the high winds of the washoe zephyr could damage your siding. and that's very different than living on park ave in sheboygan, wisconsin, where ice dams could cause water damage. but no matter what park you live on, one of 10,000 local allstate agents kno

particularly with this district with pharmaceutical companies not until they started buying all the bio pharma companies we created in this district they are one of the largest employers in the seventh congressional district and they represent a lot of people. >> what about what you proposed in congress to lower prices for those in the seventh? tee10 we should be. >>pressley: we should be negotiating those prices and i do believe we have to preserve the aca and put on a path to single-payer healthcare which will ultimately create greater access. >> how much should race and gender matter to voters? i know you said you not like identity politics am not asking that we all know it is a majority minority district but should the issues be where people stand on the issues of leadership? how much should that matter? tee10. >>pressley: that is up to the electorate i do believe government cannot be run by the people of all people are not represented but with a leader that will have that relationship with government and the organizer and immobilizer we want to protect the aca not just because they cast a

of pain and subsystem treats pain and if that philosophy sounds familiar to you it's exactly how pharma one of the biggest manufacturers of oxycontin operated they made billions by rebranding pain relief as a god given right and purging pharmacy own internal documents say produce ambition was to attach an emotional aspect to non-cancer pain so that doctors would feel pressure to treat it more seriously and aggressively it was produce marketing that spurred an opioid prices for to kills one hundred fifteen people every day now it's finally no secret that this crisis there's more families apart than having one parent who went to michigan and the other who went to ohio state but where is produce exactly have gone off without any jail time there still could be time served for instance higher ups seven and says top executives including its c.e.o. john kapoor were indicted on fraud and conspiracy charges and face trial and twenty nineteen but as long as a profit motive exists to push these drugs the name subsists will be defined as yet another opioid that got the fenceless americans hooked. a

while pharma is lagging pricing issues r weighed on regeneron.by medicare advancement rules by precision-infuszed drugs and insight h faced lower prices on a key drug. the shadministration's ck on high prices is an increasing headwind for theharma ndustry, but analyst michael yee expects the specialty drugmakers will continue to tperform. >> you have some challenges as some of the large bioteches and large pharmaceutical companies and those challenges over the last few years have driven a likely move towards acquiring many of the small and mid-cap bioteches and we believe many of the other biotechs could be acquired and there's for the speed with which the companies are prodeveloping drugs and the potential of them being taken out. >> still, the price tag of some of the new drugs in the pipeline that offer cures will be in the million dollarange which wil pose a real challenge for the nation's health system. lyfor the nig business report, i'm bertha coombs. >> that is nightpo business for tonight. i'm tyler matheson. this is t te of year your pub

medical knowledge but it's written in their language so it cannot be stolen and exploited by this a big pharma or are these you know that large corporations so that's a protection of their medical knowledge but at the same time as we look at that why should be the why should there be that conflict why can't we have this respect for approach to each other so we can share this knowledge that could possibly save some lives or improve at least improve people's lives jonathan to the big question today still how i have to show something this is from the well intellectual property organization and that reading we view of the idea that we shouldn't be having to steal other people's notations and cites we should be out of what together so they put together a fictional story of how indigenous communities can walk away with maybe become and big corporations and what to get to have a look. i organized a meeting and we agreed to talk with the cosmetics company we expressed our concerns their aging cream used our traditional knowledge we also explained how their trademark was given the impression that the c

reports say the pharma giant is also considering cutting jobs from its current 1,600 strong workforceirm currently employs 9,a00 in the country and blamed the competitve industry for the job lossses. e.0n says the cuts are part of its £100 million savings drive. tech giant apple has smashed wall street forecasts by selling more of its top end iphones than expected. profits for the second quarter — that's the last three months — jumped by 32% to £8.8 billion. london's lord mayor — charles bowman — says the uk's financial services sector won't be as hard hit by brexit as intially feared. bowman said between 5,000 and 13,000 jobs could go when the uk leaves the european union in march next year. those figures are based on the uk securing a transition deal with the eu, and contrast greatly with some independent reports which predicted as many as 65,000 jobs could go. joining me now is victoria hewson, who's the senior counsel at the institute of economic affairs. what do you make of these comments? i think it is a welcome dose of realism. some others were quite sceptical of these figures

i also continue to like fidelity's hmscilth care etf, a broad swath of everything from major pharmas to medical equipment systems as well as bio te nology. healre's low-risk, togh-return relative to the overall growth group makes it a good defensive growth play. and then on the bond side of the fence, i think hopefully everybody is relatively short in the investment grade duration space. something to complement that could be vanex angels high-yield etf. it looks at high-yield bonds that were formerly investment grade bonds that f tl offt wagon but have a chance of climbing back up. the riurn profile there, especially in a slow-growth economy, looks likt's worth a reward. that is yielding north of 5.5%. >> always a great bowie there too, by the way. >> thanks, bill. >> do you have a timeline for this? you're clearly becoming defensive, looking at slow growth. how much time are you giving yourself to see this slow growth play out? >> we're definitely going to look at what happens not just up to but through the midterm elections in how could impact policies that have clearly been creati

german company it's likely that the american position will prevail and comment briefly in a few cases pharma companies did manage to get more control over whether their products were used in executions or not what's the difference here. well in those cases the medications were very specific the companies involved in those cases found it much easier to control their distribution in the case of those medications of cuisine use a muscle relaxer and a chemical that can stop the heart function. they are widely used in the u.s. in many clinics and the state of nebraska can get them quite easily contribution in frankfurt thank you. no a group of b.m.w. owners in south korea has filed a criminal complaint against a german carmaker over alleged delays in recalling more than one hundred thousand cars that after over thirty b.m.w. vehicles caught fire this year in south korea now the german carmaker apologized on monday blaming a faulty component for customers i agree and say the firm should have issued the recall sooner the timing of recall which was issued last month is already the subject of a gover

are after companies like canopy are also developing alternative medical products potentially giving pharma companies a run for their money. so the way we pay is changing quickly while some countries like germany are more conservative when it comes to cash less payment methods in denmark cash could soon disappear right now only one in five danish retail transactions is done in cash card payment or card payments are far more common and now the head of one of the country's largest banks has joined the growing chorus calling for the country to abandon cash altogether. cash cost money for retailers twice as much as electronic payments and it raises the risks of crime. just this year the danish government loosened its requirement that stores accept cash now they can refuse it after eight pm if you are bank branches meanwhile accept bills and coins the director of denmark's third largest bank has now called for a cashless society by two thousand and twenty five. we believe there will be societal reductions in expenditures in the areas of lower crime rate lower money laundering rate lower drug cri

big cap pharma is under fire and it will remain that way for a period of time. >> next up, chipotle >ipotle has had a big move i'll trade it here i'm a buyer. i think it can continue to move on momentum, new ceo hedge funds are crowding into this because consensus is they're going to do as well as far as earnings are concerned. it's a momentum carry. it's a 2019 show me story but in the near term i want to own the stock. >> i'm fading. is that how we're owning it? i think it is a crowded trade. easy comps is important but the valuation is hard. if they don't get to that comp -- it seems like every other week there's a new situation in one of their restaurants. after the rally it's had off the lows, i don't think you buy it. >> nordstrom, trade it or fade it >> fade it we think nordstrom is a bricks and mortar company that finally has their digital game on. however, if you look at the sector,ist a high-flying sector and losing momentum. it's going to be a pretty big fish in a small pond soon. >> b.k.? >> i'm going to trade it i don't tobt need to trade it on monday, but that's a pretty

after companies like canopy are also developing and turn it into medical products potentially giving pharma companies a run for their money. right. to the story we've been following all week long to tara has come to turkey's rescue him at the currency crisis the qatari government pledged fifteen billion dollars in investments in turkey in supporting a rise in the lira and yet turkish industries are having a hard time with the country's economic turmoil inflation currency routes and a tariff conflict with the us are affecting those who sell their products abroad but not all is lost especially in an export sector that has prospered in the last twenty years now it's up to turkey's political leaders to make sure it stays afloat . jamil mares so glu has survived a few financial crises during his thirty eight year career the is to base producer of electric parts for cars and buses can still remember turkey's last economic crash that was in two thousand and one when he was forced to turn off his machines the situation today is different however. the news about turkey today has a potential export v

that percent of the other poor thing on the dangers or over the bridge and that was a report of the pharma professor from the university of general that was the thing . based was the the the finance for the collapse of the collapsing of the bridge or i could see that maybe because sometimes in italy since there are so many problems and then nothing is happening it seemed that possibly to me could seem like ok maybe it's dangerous but it's not that serious and sometimes maybe need only we need to face the tragedy before the allies in the things that actually are. serious we will see as you said later about the politicisation a bug that there were actually even in the past the british government also the weather more king are calling it there's a little fairy tale in those voices that were calling about the. danger of collapsing of the bridge that was actually the five star movement of f. i'm not wrong the found out of the five star movement is resident in general as so he should know better and i am going to go to. rico again just continue what tancredo just said i mean yes this bridge coll

have a lot of regard for those same groups that had always controlled you know in particular big pharma particular wall street some of those groups he didn't have a need for them he didn't seem to care or give them much regard or even respect and i wanted somebody who would answer to me and i think that the average democrat out there right now they want the same thing they want to politician who's not bought and sold who will answer to them and they can't find that in the democrat party like now and that's the conflict going to jump in here. i think the the political established left needs to calm down and i would give the same advice to the president of the united states outs all the time we have many thanks to my guests in new york los angeles and west palm beach and thanks to our viewers for watching us here don't he see you next time and remember crosstalk tools. finest hour from now senator you can get up now has a thousand people a point about. lining if you knew you would it be that easy to find a ten that i had in me. plus it said thank you muslims to people whom it is. good tha

to talks with states the native american nations and settlement talks with drug companies produce pharma developed oxy cotton the drug blamed for kicking off the current epidemic last week the center for disease control reported that drug overdose deaths reached a new record of seventy two thousand last year that number was up ten percent from the year before pushing overdose deaths past car crashes and hiv as causes of people's demise. does copper the humble metallic element hold the key to predicting the next global economic slowdown some market watchers are looking to history and saying yes last week copper hit a thirteen month load near two dollars and fifty five cents per pound before stabling izing a bit on friday that downward dip was the tail of a twenty percent slide copper has been on since early june when we talked about it in some detail similar turbulence in the price of other metals might be written off as the usual fluctuations of markets but dr copper as some have called it has developed a reputation as a harbinger of shifts in the economy the most dire predictors point t

have a lot of regard for those same groups that had always controlled you know in particular big pharma particular wall street some of those groups he didn't have a need for them he didn't seem to care or give them much regard or even respect and i wanted somebody who would answer to me and i think that the average democrat out there right now they want the same thing they want to pay. attention has not bought and sold who will answer to them and they can't find that in the democrat party one cow and that's the conflict ok i'm going to jump in here i think the political established left needs to calm down and i would give the same advice to the president of the united states outs all the time we have many thanks to my guests in new york los angeles and west palm beach and thanks to our viewers for watching us here to see you next time and remember crosstalk rules. but whole existence to do something to. put themselves on the line to get accepted or rejected. so when you want to be president. some want to be rich. but you going to be this is what before three of them can't be good. i'm i

. >> there would seem to be market opportunity for pharma claims processor that would not play games and deal straightly with their clients. why doesn't that exist? brian: you have some new pbm entrants into the model that a more transparent models, but when you look at pbm's today, you've got three major players that make up 70-80%, or more, of the market. it's not the easiest marketer it's an entrants business model. it's not the easiest mode break into and it is a model that is ripe for some destruction and to think we may be getting to tipping point. it was start seeing some change in the contracting model in the pharmaceutical supply chain. >> thanks. brian: yes. >> so i see there was a slight -- i didn't see if there's a slide specifically focused on cost control. i guess maybe the top initiative is the closest looking at that. brian: there is a slide in there that has what the key drivers are, the key areas that employers are focused on in terms of cost management. i know it is in there. i don't have all of the top of my head. >> i was trying to see what the leading actions to